The DOI matches its Crossref record.
Prescription Event Monitoring of Checkpoint Inhibitor-Induced Liver Injury and Outcomes of Rechallenge: A 10-Year Experience
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Steroids were administered in 59% of patients before performing a liver biopsy according to clinical guidelines, but some patients' conditions improved without the need for immunosuppression.
“Consistent with current practice, steroids were administered in 59% of patients before performing a liver biopsy according to clinical guidelines, but some patients’ conditions improved without the need for immunosuppression.”
From Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report (2023) · cites this paper as [38]
ChILI is accounting for an increasing proportion of recent DILI cohort studies.
“Checkpoint inhibitor-induced liver injury (ChILI) is accounting for an increasing proportion of recent DILI cohort studies.”
From Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report (2023) · cites this paper as [38]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 3
- De Martin E et al. Liver toxicity as a limiting factor to the increasing use of immune checkpoint inhibitors. JHEP Rep. 2020;2(6):100170. · DOI
- Aithal GP et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011;89(6):806-15. · DOI
- Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci. 2016;17(1):14. · DOI · Paper page
Cited by
Sorted by citations
Andrade, R. J., Aithal, G. P., de Boer, Y. S., Liberal, R., Gerbes, A., Regev, A., Terziroli Beretta-Piccoli, B., Schramm, C., Kleiner, D. E., De Martin, E., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.033 · Cited by 166
Self-citation
Metadata
- Authors
- Atallah, E., Oshaughnessy, A., Dolapo, I., Moore, Y., Ntata, J., Rao, A., Franks, H., Patel, P. M., & Aithal, G. P.
- Affiliations
- Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, UK; National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, UK
- Nottingham University Hospitals NHS Trust, UK
- Nottingham University Hospitals NHS Trust, UK; Centre for Cancer Sciences, Translational Medical Sciences, BioDiscovery Institute, University of Nottingham, UK
- Venue
- EMJ Hepatology
- Publisher
- European Medical Group
- Published
- 2022-08-04
- Pages
- 32-34
- ISSN
- 2053-4221
- Cited by
- 0
- References
- 0
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
